Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry refers to a novel, uncharacterized transcript located within an intronic region of the Annexin A4 (ANXA4) gene, on the sense strand. It is annotated as ENSG00000297346 in the Ensembl database, but there are no published data or experimental studies describing its protein-coding potential, biological function, clinical relevance, or pharmacological targeting. Because it is described as "sense intronic", the transcript arises from within an intron of ANXA4 in the same transcriptional orientation, and does not overlap with functional exons or known regulatory regions of ANXA4 protein. No evidence currently supports its use as a therapeutic, diagnostic, or research target. This entry is not a canonical therapeutic or research target. It is a non-coding or uncharacterized transcript with no established function, disease association, drug interactions, or biological/pathological role. All molecular features for experimental or pharmacological exploitation remain unreported.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on novel transcript, sense intronic to ANXA4 (ENSG00000297346).